Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 66801-66850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05410587
Fracture Monitor - Femur
NARecruiting
37 participants
Started: Oct 3, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor4 locations
NCT05580211
Neuromodulation for Schizophrenia
NARecruiting
34 participants
Started: Oct 3, 2023 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT06044337
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
PHASE3Enrolling by invitation
322 participants
Started: Oct 3, 2023 · Completed: Dec 11, 2029
2 conditions1 sponsor72 locations
NCT05807321
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
NARecruiting
24 participants
Started: Oct 3, 2023 · Completed: Mar 31, 2027
2 conditions3 sponsors2 locations
NCT06011863
Comparison of Pain Relief Efficacy of Epidural Analgesia and Erector Spinae Plane Block Before Thoracotomy Surgery
N/ARecruiting
42 participants
Started: Oct 3, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05871996
Palliative Care and Oncology Survey on Terminology
N/ARecruiting
1,532 participants
Started: Oct 3, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors3 locations
NCT05615649
Expanded Indications in the Pediatric BONEBRIDGE Population
NAActive, not recruiting
36 participants
Started: Oct 3, 2023 · Completed: Jul 31, 2026
2 conditions1 sponsor6 locations
NCT05902325
Identifying Predictors Of Response To Mepolizumab In CRSwNP
PHASE4Recruiting
36 participants
Started: Oct 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06002113
Eliciting Informed Goals of Care in Elderly Patients
NARecruiting
1,200 participants
Started: Oct 3, 2023 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT06142838
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
NARecruiting
1,600 participants
Started: Oct 3, 2023 · Completed: Aug 31, 2024
2 conditions4 sponsors1 location
NCT06411431
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
NARecruiting
200 participants
Started: Oct 3, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05901688
Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
N/ARecruiting
5,000 participants
Started: Oct 3, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06320639
DRIVing Simulator and People With NeuroCognitive Disorders
N/ARecruiting
150 participants
Started: Oct 3, 2023 · Completed: Oct 10, 2026
1 condition2 sponsors1 location
NCT05669547
Dual Hormone Closed Loop in Type 1 Diabetes
NAActive, not recruiting
240 participants
Started: Oct 3, 2023 · Completed: Jan 1, 2026
3 conditions3 sponsors14 locations
NCT06066606
U-LABA/ICS Effects on Exercise Performance, Vilanterol
NARecruiting
30 participants
Started: Oct 3, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06018441
A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world Setting
N/AActive, not recruiting
112 participants
Started: Oct 3, 2023 · Completed: Oct 3, 2025
1 condition1 sponsor1 location
NCT06149143
Cardiac Performance System Data Collection Study - Minnesota
N/ARecruiting
50 participants
Started: Oct 3, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06058195
Comparison of Quadratus Lumborum and Transverse Abdominis Plane Blocks With Intravenous Analgesic in Gallbladder Surgery
N/ARecruiting
128 participants
Started: Oct 3, 2023 · Completed: Feb 16, 2024
1 condition1 sponsor1 location
NCT06000774
Therapeutic Ketogenic Diet in Anorexia Nervosa
NARecruiting
20 participants
Started: Oct 3, 2023 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT05941494
Cerebral Flow-metabolism Coupling During Adult Surgery
PHASE4Recruiting
80 participants
Started: Oct 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06254820
Dose, Safety, and Pathogenicity of a New Influenza B Strain
PHASE2Recruiting
60 participants
Started: Oct 3, 2023 · Completed: Feb 8, 2024
1 condition2 sponsors1 location
NCT05586230
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
PHASE1Recruiting
72 participants
Started: Oct 3, 2023 · Completed: Jan 31, 2026
2 conditions4 sponsors6 locations
NCT06068231
A Study of Early Loading of Implants in the Maxillary Anterior Region With Alveolar Bone Defects
NARecruiting
80 participants
Started: Oct 3, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06077019
Role of Lung Function for Exercise Capacity in Well-trained Individuals
NARecruiting
60 participants
Started: Oct 3, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06126042
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
PHASE1Recruiting
330 participants
Started: Oct 3, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor3 locations
NCT06480942
Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Spontaneously Breathing Patients
N/ARecruiting
30 participants
Started: Oct 3, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06057402
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
PHASE4Recruiting
80 participants
Started: Oct 3, 2023 · Completed: Feb 22, 2032
1 condition1 sponsor19 locations
NCT06155292
Report Cards and Feedback for PCCE
NARecruiting
330 participants
Started: Oct 3, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT04680065
GDNF Gene Therapy for Multiple System Atrophy
PHASE1Active, not recruiting
9 participants
Started: Oct 3, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor7 locations
NCT05812157
Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
NARecruiting
36 participants
Started: Oct 2, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor3 locations
NCT05892718
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
PHASE1Recruiting
60 participants
Started: Oct 2, 2023 · Completed: Nov 15, 2029
2 conditions1 sponsor8 locations
NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
PHASE2Recruiting
400 participants
Started: Oct 2, 2023 · Completed: Jun 30, 2032
1 condition3 sponsors31 locations
NCT06076655
Hallux Valgus Treatment Developed for Children With Cerebral Palsy
NANot yet recruiting
15 participants
Started: Oct 2, 2023 · Completed: Jan 1, 2024
1 condition1 sponsor0 locations
NCT05881733
Effect of a Bigger Cryoballoon on the Total Antral Lesion Size: Evaluation of POLARx FIT
NAActive, not recruiting
20 participants
Started: Oct 2, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05799092
Invasive Versus Non-invasive Approach in Symptomatic Patient With Non-High Risk Coronary Artery Stenosis
NARecruiting
2,000 participants
Started: Oct 2, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06067204
Automatic Ventilation in Prehospital Resuscitation on OHCA
NARecruiting
514 participants
Started: Oct 2, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06021288
Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )
NARecruiting
165 participants
Started: Oct 2, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor2 locations
NCT05796193
Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote D'Ivoire
NAActive, not recruiting
1,650 participants
Started: Oct 2, 2023 · Completed: Dec 31, 2024
1 condition4 sponsors1 location
NCT06139055
A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
PHASE1Active, not recruiting
70 participants
Started: Oct 2, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor3 locations
NCT05839119
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
PHASE1Recruiting
32 participants
Started: Oct 2, 2023 · Completed: Jan 1, 2032
2 conditions4 sponsors1 location
NCT05669027
Mobile Neurofeedback for Low Back Pain
NARecruiting
150 participants
Started: Oct 2, 2023 · Completed: May 1, 2027
1 condition3 sponsors1 location
NCT05943496
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
PHASE1Recruiting
27 participants
Started: Oct 2, 2023 · Completed: Jan 1, 2027
1 condition3 sponsors1 location
NCT05617326
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
NARecruiting
400 participants
Started: Oct 2, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor4 locations
NCT05777031
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
PHASE4Recruiting
22 participants
Started: Oct 2, 2023 · Completed: Jan 15, 2026
3 conditions2 sponsors2 locations
NCT05659797
FES BPET-DBT in Newly Diagnosed Breast Cancer
EARLY_PHASE1Recruiting
20 participants
Started: Oct 2, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05826665
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
N/ARecruiting
200 participants
Started: Oct 2, 2023 · Completed: Jul 31, 2025
1 condition4 sponsors4 locations
NCT05794646
Community Intervention to Eliminate HCV Among People Who Use Drugs.
NAActive, not recruiting
3,400 participants
Started: Oct 2, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor4 locations
NCT06296017
Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
NARecruiting
54 participants
Started: Oct 2, 2023 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT06134128
Compensatory Cognitive Training Via Telehealth for Veterans with Alcohol Use Disorders
NAActive, not recruiting
30 participants
Started: Oct 2, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06005532
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
PHASE3Recruiting
494 participants
Started: Oct 2, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations